North Carolina Senate Passes Medical Cannabis Bill

a word from our sponsors:

advertisement

advertise here

The North Carolina Senate on Tuesday passed a medical cannabis legalization bill, WRAL reports. It marks the second year in a row the chamber has approved a medical cannabis bill; however, the measure died in the House in 2022.

The bill received bipartisan support, passing by a 36-10 margin. The legislation is largely the same as the measure that passed the Senate by a 36-7 vote last year.

Republican state Sen. Bill Rabon, the bill’s lead sponsor, told WRAL that he believes the reforms have more support in the House this year. The measure was never brought up for a vote in 2022.

“The purpose of the bill is to allow for tightly regulated use of medical cannabis, only by those with debilitating illnesses … The recreational sale or use of marijuana remains, under this legislation, illegal.” — Rabon, during the Senate debate, via WRAL

The qualifying conditions list to allow patients to access medical cannabis includes cancer, epilepsy, HIV, AIDS, amyotrophic lateral sclerosis (ALS), Crohn’s disease, sickle cell anemia, Parkinson’s disease, post-traumatic stress disorder (PTSD), multiple sclerosis, cachexia or wasting syndrome, severe or persistent nausea in a person who is not pregnant that is related to end-of-life or hospice care, or who is bedridden or homebound because of a condition, terminal illness when the patient’s remaining life expectancy is less than six months, and conditions resulting in the individual receiving hospice care, according to the bill text.

The Senate-approved version includes stricter rules on marketing than the previous version, allowing 10 companies to sell medical cannabis with a maximum of eight stores each. The measure moves next to the House after a second, confirmation vote on Wednesday.

End


New Mexico Cannabis Bill Filed

New Mexico Bill Would Create Two New Funds for Cannabis Tax Revenues

a word from our sponsors:

advertisement

advertise here

A bill in New Mexico would create two new programs funded by cannabis excise tax revenues, including a community reinvestment grant fund and a substance use disorder prevention and treatment fund, KRQE reports. Currently, all cannabis excise tax revenues are sent into the state’s general fund. 

Under the measure, a third of the taxes collected from adult-use sales would be used for those programs. State Rep. Andrea Romero (D), one of the bill’s sponsors, noted that the current version of the bill does not specify that the money would come from the state’s share of revenues, not cities or counties, and that the changes would be made to the bill in committee before it moves to the floor for a vote.  

“This was always the intent of the cannabis legislation was to reinvest into these programs but now that we have this incredible funding coming into the state as new revenue, we can finally make good on that promise to New Mexicans about what we care about investing in.” — Romero via KRQE 

New Mexico is currently collecting slightly more than $2.5 million a month from the 12% excise tax on adult-use cannabis sales. 

The measure was tabled in committee but will be considered in the next session. 

End


California Cannabis Sales Decline for First Time Since Adult-Use Launch

a word from our sponsors:

advertisement

advertise here

Cannabis sales in California declined in 2022 for the first time since the launch of the adult-use market in 2018, according to Department of Tax and Fee Administration (DTFA) data outlined by Forbes. In all, sales dropped 8.2% to $5.3 billion from the $5.77 in sales last year. 

California still represents 20% of the nation’s $26 billion legal cannabis industry, the report says. 

The wholesale price for cannabis in California was down last year by 26% year-over-year to $665 a pound. Since 2017, the year prior to the launch of legal sales, California cannabis wholesale prices are down about 50%, according to a New Leaf Data Services report outlined by Forbes.  

Pablo Zuanic, an analyst at Cantor Fitzgerald who covers cannabis, told Forbes he believes that mature markets like California saw a revenue boost in 2020 and 2021 due to increased consumption during the Covid-19 pandemic and that the end of pandemic-era policies, including stimulus checks, paired with rising inflation, have added to the decline. He noted that there was “only” an 8% drop after a 23% increase in 2021 and a 68% increase in 2020.   

California has about 1,000 dispensaries serving the state’s more than 40 million residents but 60% of California jurisdictions – or 33 counties – do not allow adult-use cannabis businesses within their borders. Last month, officials launched a $20 million grant program to increase legal cannabis access throughout the state. The grant will prioritize areas where national surveys find high cannabis consumption but have little to no access to cannabis retailers, officials said, adding that the program “seeks to incentivize local best practices by prioritizing programs that support equity operators and utilize existing licensing and permitting practices.”

End


Utah Officials Warn of Medical Cannabis Scam

a word from our sponsors:

advertisement

advertise here

The Utah Department of Agriculture and Food (UDAF) is warning about potential medical cannabis program scams. The agency pointed to an ad found in a newspaper from Planted which claims Utah “is offering cannabis dispensary licenses to persons convicted of a cannabis offense.” 

Utah does not allow cannabis sales at dispensaries and medical cannabis products are only available through licensed pharmacies.

In a press release, Utah Department of Agriculture and Food (UDAF) Medical Cannabis Division Director, Dr. Brandon Forsyth said that “any offers stating that individuals can create their own dispensaries are false and considered scams.” 

“It has been brought to our attention that there is a scam, or potentially multiple scams, being shared throughout the state making false claims that the individuals may be eligible to open their own cannabis dispensary.” — Forsyth in a statement 

The UDAF is urging residents not to call any numbers or visit any websites associated with the ads and to contact UDAF officials if they come across any similar ads with the fake claims.  

The Planted website listed on the ad does not contain any additional information. The website includes the same text used in the Utah ad along with a short questionnaire. The phone number included on the website has an Idaho area code and is different from the phone number featured in the Utah ad.    

End


Tennessee Medical Cannabis Legalization Bill Dies in Senate Committee

a word from our sponsors:

advertisement

advertise here

The bill to legalize medical cannabis in Tennessee died in the Senate Judiciary Committee on Tuesday on a nearly party-line vote, WKRN reports. The measure, sponsored by Republican Sen. Janice Bowling, got support from only one Republican – Sen. Kerry Roberts. 

The bill’s failure is the second cannabis-related legislation to be rejected by a legislative panel this session after a measure to add three nonbinding cannabis poll questions to general election ballots in 2024 was quashed by the House Elections and Campaign Finance Subcommittee last week. That bill would have asked voters whether medical cannabis should be legalized, whether possession of less than one ounce of cannabis should be decriminalized, and whether adult-use cannabis should be legalized, according to a WKRN report.   

There is still one medical cannabis bill that could be considered by lawmakers in the General Subcommittee of the Senate Judiciary Committee. That measure, sponsored by Democratic Rep. Jesse Chism, was taken off the House calendar last month but could be revived if it is approved by the Senate subcommittee.  

In an interview with WKRN, Chism said that from his district, which includes Memphis, “you can throw a rock and hit either Mississippi or Arkansas,” which both allow medical cannabis access. 

“So, you have so many people who are leaving the state of Tennessee to go have access to medical help that they cannot have in Tennessee,” he said. 

End


USDA Report: Hemp Planting Off to Slower Start Than in 2022

a word from our sponsors:

advertisement

advertise here

Hemp planting in the U.S. is off to a slower start this year compared to the same period in 2022, according to the U.S. Department of Agriculture’s (USDA) National Weekly Hemp Report. So far this year, less than 10 acres of hemp have been reported to the Farm Service Agency (FSA), down from about 100 acres reported to the FSA last year. 

According to the report, most of the hemp planted is being cultivated for seed production and cannabinoid extraction.  

The agency said that retail ad totals for hemp products were up 12% from last week and 14% from 2022 while the number of hemp items advertised fell by only one item. Hemp item prices were reportedly down overall in the weekly report, except for a 25% increase in the price of 16 oz. organic hemp seed. Price decreases were “only slight,” the report notes, except for a 19% decrease for 7 oz. organic hemp seed. Hemp prices remained stable in Hawaii.

The USDA launched the weekly National Hemp Report late last month. The report contains retail advertised prices of hemp products nationally and by region, along with volumes and cost, insurance, and freight values of hemp imports into the U.S.

In a statement announcing the new report, Under Secretary for Marketing and Regulatory Programs Jenny Lester Moffitt said the USDA “has recognized the hemp industry’s need for timely market information” and the report “will equip stakeholders with weekly price and volume information to help guide smart business decisions.” 

The report will be issued every Wednesday.      

End


Virginia Lawmakers Pass Bill to Limit Hemp Product THC Levels

a word from our sponsors:

advertisement

advertise here

Virginia lawmakers last week passed a bill to cap THC levels, create a more robust permitting system, and enact stricter labeling rules for hemp-derived products with intoxicating THC levels, such as delta-8 products, the Virginia Mercury reports. The measure passed both the House and Senate last Friday. 

The bill limits THC in hemp-derived THC products at 2 milligrams and also includes a provision requiring topical products containing hemp-derived cannabinoids to include bittering products to prevent people from consuming them to get high.  

Brad Wynne, co-owner of hemp skincare company Veg Out Organics, told WAVY that adding the bittering chemicals to their products will render them almost useless.

“The THC cap is a problem, and what affects really us is they want us to put bittering agents, toxic chemicals into topicals because they think people will take these cleansers, moisturizers and chug it – eat it for the little bit of THC, which doesn’t make any sense.” — Wynne to WAVY 

Katie Wynn, Veg Out co-owner, said the new rules are going to “put hemp farmers, growers, processers, businesses all out of business.” 

“I know it’s a vote to some of them,” she told WAVY, “but for us, it’s our livelihood.” 

Sen. Scott Surovell (D) said during the debate that a provision in the bill that splits cannabis regulatory oversight between the Virginia Department of Agriculture and Consumer Services and the new Virginia Cannabis Control Authority “is the first step toward a complete mess.” He said the bill was introduced and passed “because somebody upstairs doesn’t want to talk about it”; likely referring to Republican Gov. Glenn Youngkin.  

Youngkin was elected after lawmakers passed an adult-use legalization measure and has led efforts to block implementation bills to create the market. The bill approved on Friday originated with Youngkin’s office which almost guarantees that he will sign it into law. 

End


South Dakota Bill Aims to Raise THC Levels for Hemp Processing

a word from our sponsors:

advertisement

advertise here

A South Dakota bill that would raise the THC levels allowed for hemp transported between processors in the state from 1% to 5% passed the Senate Agriculture and Natural Resources Committee last week on a 4-3 vote, KELO reports. The measure would not change the THC levels – .3% – allowed in retail hemp products.     

Rep. Oren Lesmeister (D), the bill sponsor, testified to the committee that raising the THC threshold to 5% would allow for another processor to extract THC as it develops more uses for hemp after the initial process is completed. Hemp often contains between 1% and 5% THC and those levels can increase during processing. 

Katie Sieverding, of the South Dakota Industrial Hemp Association, told the panel that other states that don’t implicitly allow a 5% THC threshold while processing are ignoring the facts and that raising the threshold would allow more hemp processors to be licensed in the state. 

If approved, the hemp would be transported between processors in containers marked “not for human consumption,” according to the bill text.  

The measure is expected to be heard next by the full Senate, who deferred hearing the bill on February 24. The measure has not yet been heard by any House committees.  

End


Cannabis Sales in Arizona Top $1.4B in 2022

a word from our sponsors:

advertisement

advertise here

Cannabis sales in Arizona topped $1.4 billion last year with adult-use sales comprising about 70% of the total, AZ Mirror reports. The total was nearly identical to Arizona’s 2021 sales; however, in 2021 medical cannabis sales made up about 55% of the state’s total cannabis sales.  

Arizona adult-use cannabis sales reached their peak in December with about $86.6 million, an increase of nearly $1 million from the $85.8 million the previous month. Meanwhile, medical cannabis sales from November to December dropped from $31.9 million to $31.1 million. 

Since the launch of adult-use sales in Arizona in January 2021, cannabis sales from both adult-use and recreational markets have reached $2.9 billion, the report says. The lowest full month total of adult-use cannabis sales in the state was about $40 million in February 2021, the first full month of adult-use sales.  

Medical cannabis sales have declined nearly every month since April 2021, when sales reached $73.2 million, the report says. In July 2021 sales hit $71.6 million after a $5 million decrease the previous month and medical cannabis sales have never come close to that total again and the last time medical cannabis patients spent more than $50 million in a month was April 2022, the report says. 

The state collects 16% excise tax on adult-use sales along with the state’s standard sales tax. Medical cannabis patients pay roughly 6% in state sales tax and municipalities can charge an additional 2% or so for all cannabis sales that occur within their jurisdictions. 

A third of adult-use taxes collected are earmarked for community college and provisional community college districts; 31% to public safety, 25% to the Arizona Highway User Revenue Fund, and 10% to the justice reinvestment fund. 

End


Yale School of Medicine Launches Cannabis & Cannabinoids Science Center

a word from our sponsors:

advertisement

advertise here

Yale School of Medicine last month announced the creation of the Center for the Science of Cannabis and Cannabinoids. The center will be led by Deepak Cyril D’Souza, MD, of the Albert E. Kent Professor of Psychiatry and a leading expert on the pharmacology of cannabinoids. 

In an interview with Yale News, D’Souza said one of his goals as director is “to bring people together.”  

“An important aspect of a center is to bring people who might have complementary interests and skillsets together in a way that may not have been previously possible. I’d like to create a forum where on a regular basis people can come together to discuss ongoing projects and avenues for collaboration.” — D’Souza to Yale News 

Additionally, D’Souza said, he wants to ensure the center is “self-sustaining.” 

“You need resources to support a center and while the dean’s office and chair of psychiatry have generously contributed funding to start a pilot program, we’d like to submit a large grant application in two to three years,” he said. “That kind of grant would sustain the center over a greater period of time.” 

D’Souza indicated that the center’s “broad interest” right now is “the impact of cannabis on the developing brain and on mental health” but that as the center greenlights pilot projects, “the center’s goals may become more focused.”  

“But we’ll approach questions from different angles. For instance, there are observational studies we can do with humans and experimental studies that we cannot,” he said. “So that’s where complementary approaches come in, where animal studies or studies in brain organoids become relevant and complementary to human work.” 

He said the center would not take a pro- or anti-cannabis legalization stance and that researchers “just want to collect information on the science of cannabis and cannabinoids.”  

Yale is located in Connecticut, where adult-use sales launched last month. 

End


Future Files Trademark Applications for Cannabis Brand

a word from our sponsors:

advertisement

advertise here

Hip-hop artist Future may be launching a cannabis brand. Trademark attorney Clarissa Harvey on Twitter last week revealed the rapper’s legal team filed six intent-to-use trademark applications for “EVOL BY FUTURE” that would be used in connection with consumption lounge services, vape pens, and medical cannabis products. 

The applications were filed on February 17. 

The filing also includes a website that would feature “health information in the field of medical marijuana and cannabis.” EVOL is the name of Future’s 2016 album.  

One of the applications outlines plans for a line of “herbal tinctures for medical purposes; medicated oils; medicated oral sprays, namely, medicated oral sprays for pain relief; medicated creams and lotions, namely, medicated pain relief creams and lotions,” according to the filing. Other applications in the filing are for a variety of smoking accessories, and clothing including hats and shirts.   

None of the trademark applications associated with the filing have been approved by the U.S. Patent and Trademark Office. The applications were filed on Future’s behalf by Joel R. Feldman of Greenberg Traurig, LLP of Atlanta, Georgia.

Other rappers, including Snoop Dogg, Jay-Z, Wiz Khalifa, B. Real, Berner, Run the Jewels, Rick Ross, and Xzibit, have ties to the cannabis industry either as investors or with their own brands.  

End


Michigan Suspends Processor’s License for Using Illicit Cannabis in Production

a word from our sponsors:

advertisement

advertise here

Michigan regulators have suspended the medical and adult-use cannabis licenses of TAS Asset Holdings after it found its products were combined with unregulated cannabis product before being sold in the regulated market. 

The affected products were marketed under the “Fwaygo Extracts” brand and produced between November 10, 2022, and November 17, 2022. 

Cannabis Regulatory Agency (CRA) Executive Director Brian Hanna said regulators are seeking revocation of TAS’ licenses.

“The conduct alleged in the formal complaints is a significant risk to the public health and safety of marijuana consumers in Michigan. … It is vital that all licensees throughout the state realize that the CRA will continue to do what it takes to protect the public from bad actors in the regulated market.” — Hanna in a press release 

The CRA’s formal complaints allege that on September 16, 2022, two packages of vape cartridges failed safety compliance testing for Bifenthrin, a chemical banned from use in Michigan’s regulated cannabis market, and before they were transferred to and processed by TAS, both packages had passed full safety compliance testing with no Bifenthrin detected. 

The CRA investigated the cause of the safety compliance test failure and video surveillance footage showed that the product used to make the vape cartridges was not the same product recorded in Metrc, which had passed compliance testing. The product used to make the vape cartridges had not been processed or entered into Metrc as being a part of the regulated market, the CRA said.

During the investigation, CRA staff noted that the business had many areas that were dirty and cluttered and had leaking containers of various process stages of cannabis and waste. CRA investigators also reported an unapproved, unlicensed warehouse being used as a part of the licensed business and observed various untagged products including flower, distillate, concentrates, and THCa powder in the unapproved warehouse. Additionally, CRA investigators uncovered three barrels of an unknown substance that were wrapped in plastic, two black totes of an unknown substance, and several mason jars of oil. No surveillance cameras were in the unapproved room, and none of the cannabis products found in that room had Metrc tags, the CRA said. 

A TAS representative admitted to regulators that the business’s signature product, “Space Rocks,” was produced using the untagged THCa powder and the investigation found that TAS was storing and interchanging unregulated cannabis products with regulated products found at the business. A safe on the premises contained three jars of distillate and five jars of concentrate that did not have Metrc tags. A review of video surveillance footage showed that TAS employees were bringing additional unregulated, untagged product into the business from their personal vehicles which could not be tracked to a licensed business. 

In all, TAS was hit with 23 regulatory violations.

End


Former DNC Political Operative Sued for Fraud by South Dakota Cannabis Companies

a word from our sponsors:

advertisement

advertise here

A former political operative for the Democratic National Committee (DNC) is being sued in South Dakota, accused of defrauding two medical cannabis companies and their investors of about $1.7 million, the Star Tribune reports. Dakota Natural Growers, 605 Cannabis, and more than 20 of their investors filed the lawsuit last month against Will Hailer, eSt Ventures LLC, Badlands Fund GP LLC, and Badlands Ventures LLC claiming that Hailer and the three funds, which Hailer manages, solicited a total of $3.5 million in investments with the “intention of stealing and/or misappropriating most of the money.”

Hailer has served as a senior advisor for the DNC, as a campaign manager for current Minnesota Attorney General Keith Ellison, and as executive director for the Texas Democratic Party.

According to the lawsuit, the cannabis firms had found investors who would invest $3.5 million into the companies but Hailer approached the owners early last year and allegedly promised if they entrusted him with that $3.5 million, he could raise another $10 million to equally invest in Dakota Natural Growers and 605 Cannabis. The capital raise was controlled through eSt Ventures and the investors.

The investors obliged and put the $3.5 million into the Badlands Ventures fund, according to the lawsuit. In court documents, the plaintiffs argue that “the defendants never secured any other investor, for any amount.” Hailer and Badlands GP ultimately returned $1.8 million but the remaining balance was never returned. The parties reached a settlement agreement last year that would have had Badlands Ventures pay about $1 million to Dakota Natural Growers and about $600,000 to 605 Cannabis, and a document filed in court shows the agreement was signed by Hailer but the money was never sent, according to the lawsuit.

The plaintiffs are seeking the return of $1.68 million plus attorney fees and unspecified “punitive damages.”

End


Dr. Greenthumb’s Ends Los Angeles Partnership with LAHC Inc.

a word from our sponsors:

advertisement

advertise here

Dr. Greenthumb’s Worldwide, founded by legendary hip-hop artist B Real of Cypress Hill, and LAHC Inc., a multi-year partner at Dr. Greenthumb’s dTLA dispensary location, have mutually decided to part ways, according to a recent press release.

The shift is due to the quickly changing landscape of California’s cannabis industry, the press release said, as both parties have sought more control over the brand’s direction and operations. After finding themselves unable to negotiate an agreeable path, both parties elected to move forward each focused on their own enterprises.

Going forward, customers should see a gradual change at DTLA’s 2019 Pasadena Ave. Los Angeles store. Furthermore, Dr. Greenthumb’s Worldwide has begun construction at a new Van Nuys dispensary, opening later in the spring of 2023, and a location in Oxnard, expected shortly after the Van Nuys site.

Dr. Greenthumb’s Worldwide representatives said the brand was grateful for the ongoing support of the store’s employees and the service provided to the brand’s fanbase.

“LAHC has played an integral part in the overall brand’s success and we wish them the best as they step in a different direction.” — Dr. Greenthumb’s Worldwide statement

B Real announced plans to build a more active and hands-on managerial model to continue scaling his enterprise and vision, with the mission of amplifying and extending a “culture that honors individuals who are unapologetically themselves.”

End


Massachusetts’ Harpoon Brewery Launches its First THC Beverage

a word from our sponsors:

advertisement

advertise here

Harpoon Brewery has launched its first THC-based beverage, Rec. Weed, in partnership with Novel Beverage Company. The company describes Rec. Weed as “hop-forward yet approachable.” It contains no alcohol, 5 milligrams of THC, real passionfruit puree, green tea, and hops. 

Dan Kenary, CEO and co-founder of Harpoon, said it partnered with Novel on the product because of its “vast knowledge” of the cannabis industry and “strong New England roots.” Both companies are based in Massachusetts.

“The adult beverage space is constantly evolving. With THC now legalized in states across much of the country – especially here in the Northeast – we saw not only high demand for a THC-based beverage, but an opportunity to experiment in a way that would uniquely leverage our strengths in the beer world.” — Kenary in a press release 

Rec. Weed is the second cannabis-inspired product from Harpoon’s parent company, Mass. Bay Brewing Company, after previously launching Long Trail’s CBD Seltzer. The CBD Seltzer is available in Connecticut, Massachusetts, New Jersey, Rhode Island, and Vermont.  

Rec. Weed is currently only available at adult-use dispensaries in Massachusetts. Novel products are available at adult-use cannabis dispensaries in Maine and Massachusetts. Novel has also worked with Shipyard Brewing and Sea Dog Brewing on cannabis beverages.  

End


Dr. Dabber XS Mini-E-Rig Review

a word from our sponsors:

advertisement

advertise here

The Dr. Dabber XS is the latest offering from a leader in the E-rig space that takes portable dabbing to the next, but smaller, level. Known for their Boost Evo and Switch rigs, Dr Dabber’s latest piece puts filtered concentrate consumption in your pocket or hand bag. But, don’t be fooled, the devices’ minimal size does not take away from the unit’s functionality, however.

The Dr. Dabber XS is made up of four pieces: a spill-proof glass bubbler attachment, a ceramic atomizer, the glass carb cap, and the battery unit/base. The XS fits together easily — just screw in the atomizer to the battery; place the glass bubbler, after adding the water, over the atomizer, noticing the tight seal; and lastly, add the carb cap, another tight fit, and the Dr. Dabber XS is just about ready to fire. There are a few more accessories that make the unit complete: a dab tool, a silicon collar to hold the carb cap, a handy tiny funnel — it’s so cute — to fill the bubbler, and even some alcohol-infused cotton q-tips to clean the atomizer and glass bubbler.

Once it’s all put together, the bubbler is bubbling, and the concentrate is loaded, it only takes five clicks on the power button and then a five-second hold before the vape gets flowing. The XS has four temperature settings: 475°, 525°, 575° and 625°. Three quick taps on the power button will change the temp, which is indicated by different colors with green being the hottest. The XS takes about 20 seconds to heat up and is hot just long enough for a tasty dab hit.

There are lots of things I like about the Dr. Dabber XS. Besides the great vapor production, ergonomic heavy base/long-lasting battery unit, and glass bubbler, it is extremely easy to add concentrates, a great feature for patients like myself, blind, who have trouble using traditional concentrate devices. The battery heft gives the XS a solid feel, and if it tips over, the no-spill bubbler saves the day. The alcohol-soaked q-tips will come in handy pretty quickly though, so be ready to keep the XS cleaned up.

Visit the company website to find out more about the Dr. Dabber XS or to purchase an XS for yourself.

End


California Launches Grant Program to Expand Retail Cannabis Access

a word from our sponsors:

advertisement

advertise here

The California Department of Cannabis Control (DCC) last week launched a $20 million grant program to expand consumer access to regulated cannabis, which the agency is calling “a national first-of-its-kind.”

The grant will prioritize areas where national surveys find high cannabis consumption but have little to no access to cannabis retailers, the DCC said in a press release. The program “seeks to incentivize local best practices by prioritizing programs that support equity operators and utilize existing licensing and permitting practices,” the agency said.

In a statement, DCC Director Nicole Elliott called expanding access to retail cannabis sales “an important step towards protecting consumer safety and supporting a balanced market.”

“The retail access grant program ultimately seeks to encourage legal retail operations in areas where existing consumers do not have convenient access to regulated cannabis.” — Elliott in a statement

The DCC indicates that more than 60% of California jurisdictions do not offer local licensing for adult-use cannabis sales and that the grants “can provide much-needed assistance to cities and counties.”

The DCC said that of the 33 counties in California that currently do not offer cannabis licenses, there are nine where the rates of cannabis consumption are substantial despite only having zero or one licensed retailer. In four of the nine counties – Butte, Glenn, Madera, and Sutter – there are no licensed cannabis retailers.

Localities can use the funds to support equity applicants and licensees, for environmental reviews, permitting expenses, and personnel costs. The agency will initially award up to $10 million in grants by June 20, 2023 and after June 30, 2023, an additional $10 million will be available to previous awardees as they issue licenses.

End


Washington Senate Passes Ban on Cannabis-Related Hiring Discrimination

a word from our sponsors:

advertisement

advertise here

The Washington Senate voted 28-21 in favor of a bill on Wednesday that would block employers in the state from refusing to hire someone because they tested positive for cannabis on a drug test, the Seattle Times reports.

The bill’s sponsor, Sen. Karen Keiser (D), introduced a similar bill last year but the proposal never reached the floor for consideration. The proposal moves next to the Washington House of Representatives.

The Senate-approved ban would not apply to positions where on-duty impairment could carry “substantial risk of death,” such as in the airline and aerospace industries. Other positions that are exempt from the ban include those which require federal background checks or security clearances, the report said. Additionally, the bill only applies to drug tests performed during the hiring process and would not affect employers’ ability to drug test current employees.

“If your employer wants to test you every week after you’re hired, they’re still able to do that. This is simply opening the front door of getting into a job. Because too many people who see that they have to take a drug test to even apply, don’t even apply.” — Keiser, via the Seattle Times

Sen. Derek Stanford (D) — one of the bill’s co-sponsors — told KOMO News that, ”When people are using legal substances like cannabis away from work, we don’t think that should be a barrier to just applying for the job.”

In 2019, Nevada became the first state to prohibit employers from drug testing applicants for cannabis use during pre-employment.

End


Vermont Cannabis Sales Reach $5.7M in January

a word from our sponsors:

advertisement

advertise here

Cannabis sales in Vermont reached $5.7 million in January, according to Agency of Administration data released last week. The state collected more than $1 million in tax revenues from cannabis sales.  

Vermont collected $799,102 from the 14% excise tax on cannabis sales and $342,472 from the state’s regular 6% sales tax. Under the state’s adult-use law, cannabis excise tax revenues are used to “backfill” any deficit in the Cannabis Control Board’s budget and, after that, 70% is sent to the state’s general fund with 30% earmarked for substance misuse and prevention programs. Cannabis-derived sales taxes are used for after-school and summer education programs.      

There are currently about 40 licensed cannabis retailers in the state. 

The state legislature’s Joint Fiscal Office estimated that annual cannabis-derived taxes would range from $3.3 million to $9.1 million, according to a Seven Days report, which equates to monthly excise tax revenues between $275,000 and $758,000.  

The Cannabis Control Board projects the state will make about $16 million from the cannabis excise tax in its first full fiscal year, WCAX reports. According to state data outlined by Heady Vermont, retail cannabis sales surpassed $6 million last year. 

End


Connecticut Bill Would Create Cannabis Ombudsman Position

a word from our sponsors:

advertisement

advertise here

A bill proposed in Connecticut would create the position of Cannabis Ombudsman – an independent person that would serve as a liaison between medical cannabis patients and the state to address concerns, NBC Connecticut reports. The move comes about a month after adult-use cannabis sales commenced in the state which has caused complaints among registered patients of reduced choices for medical cannabis products.

House Majority Leader Jason Rojas (D), who sponsored the legislation, said the measure would improve quality and safety for medical cannabis patients.

In a statement, Department of Consumer Protection Commissioner Michelle Seagull said the agency is “aware some patients have expressed concerns regarding the availability of certain products following the opening of the adult-use market and the increase in the allotment for medical marijuana patients to five ounces per month.”

“The department is monitoring and evaluating the information in the seed-to-sale tracking system, complaints, and the medical preservation plans, as well as communicating with the producers as necessary.” — Seagull in a statement

Medical Cannabis Patient Advocate Lou Rinaldi told NBC Connecticut that oversight in the state “so far has largely not been in service to patients.”

“They do not have a voice in the program,” he said.

The proposal is currently in the Connecticut– House and Senate committees on General Law.

End


North Carolina Medical Cannabis Bill Passes First Senate Committee

a word from our sponsors:

advertisement

advertise here

The North Carolina Senate Judiciary Committee on Tuesday approved a proposed medical cannabis bill, moving it next to the chamber’s Finance Committee, the News & Observer reports. It’s the first vote for the measure that was introduced last month. 

The legislation would allow patients with qualifying conditions to access medical cannabis in the state. The qualifying conditions list includes cancer, epilepsy, HIV, AIDS, amyotrophic lateral sclerosis (ALS), Crohn’s disease, sickle cell anemia, Parkinson’s disease, post-traumatic stress disorder (PTSD), multiple sclerosis, cachexia or wasting syndrome, severe or persistent nausea in a person who is not pregnant that is related to end-of-life or hospice care, or who is bedridden or homebound because of a condition, terminal illness when the patient’s remaining life expectancy is less than six months, and conditions resulting in the individual receiving hospice care, according to the bill text. 

State Sen. Bill Rabon (R), one of the bill sponsors, told the News & Observer that the legislation’s goal “is to only make changes to existing state law that are necessary to protect patients and their doctors from criminal and civil penalties and would not intend to change current civil and criminal laws for the use of non medical marijuana.” 

The Judiciary Committee amended the measure to allow law enforcement agencies to contact the Department of Health and Human Services to confirm a medical cardholder’s identity if they are unable to do so through the registry system.  

Last year, a medical cannabis bill passed the Senate with bipartisan support but died in the House.  

If approved by the Finance Committee, the bill would move next to the Senate Rules and Operations Committee.  

End


Connecticut AG Sues Over Delta-8 Products that Mimic Child-Friendly Products

a word from our sponsors:

advertisement

advertise here

Connecticut Attorney General William Tong is suing five retailers over the illegal sale of delta-8 THC products that mimic products that appeal to children under the state’s Unfair Trade Practices Act. Tong is also sending letters to all vape products retailers in the state warning them of selling such products without the proper license. 

“If you offer delta-8 THC products for sale in your establishment that exceed .3 percent THC on a dry weight basis and you do not hold such a license, you are in violation of Connecticut law. For your information, we have included below photographs of products that were recently purchased from retailers in Connecticut that purport to contain delta-8 THC. The sale of such products may expose you to criminal and civil liability. Please remove any such products from your shelves and dispose of them immediately.” — Tong in the letter 

In a statement, Tong said that, “Any unlicensed Connecticut retailer selling delta-8 THC products that purport to contain high levels of THC is breaking the law and may be subject to both criminal and civil penalties.” 

Tong said the letter and lawsuits follow an undercover investigation that “revealed widespread sale of untested, unregulated, delta-8 edibles mimicking popular youth snacks” and that the five retailers served with lawsuits “offered some of the most egregious look-alike edibles posing the worst risks for accidental youth poisoning.”

The attorney general’s investigation uncovered products that mimicked popular candies and snacks such as Skittles, Warheads, Lifesavers Gummies, Nerds Rope, Gobstopper Chewy, Sour Patch Kids, Airheads, Fritos, Rice Krispies, and Cocoa Pebbles.

The lawsuits were filed against Raheem Mini Mart and AZ Smoke Shop and Wireless in Manchester, Smokers Paradise and 7 Puff in East Hartford, and Anthony’s Service Station Inc. In Plainville.

End


Iowa Democrats Unveil Adult-Use Cannabis Legalization Bill

a word from our sponsors:

advertisement

advertise here

Iowa House Democrats on Tuesday unveiled legislation to legalize cannabis for adult use, Iowa Capital Dispatch reports. Lawmakers, however, stopped short of formally introducing the measure which would legalize cannabis products with up to 500 milligrams of THC for adults 21-and-older. 

House Minority Whip Rep. Lindsay James said the proposal “will keep Iowans safe” while preventing tax dollars from “going to neighboring states.” She said the measure would also “improve the quality of life for Iowans suffering from chronic illnesses and stop wasting state resources to unfairly punish Iowans.”  

Iowa is bordered by Illinois which legalized adult cannabis use in 2020 and Missouri where adult-use cannabis sales launched this month.   

Iowa does have a low-THC medical cannabis program. In 2022, medical cannabis sales in the state reached $10 million. 

The legalization bill includes a 10% excise tax on cannabis sales and counties would have the option of imposing an addition 1% surcharge on state and local taxes derived from cannabis sales. Under the measure, cannabis excise taxes would be used for education, mental health services, and local public safety. 

The measure faces an uphill battle as Republicans control both legislative chambers and the governor’s office. Last year, Rep. Steven Holt, chair of the House Judiciary Committee, said he would “never support” cannabis legalization, according to the Capital Dispatch. 

A poll released in 2020 found 53% of Iowans support the reforms. 

End


Is Spain Likely to Pass Cannabis Reforms In 2023?

a word from our sponsors:

advertisement

advertise here

Editor’s note: This editorial was contributed by Johnny Green, Media and Content Director for the International Cannabis Business Conference.

Cannabis reform is on the move across the globe, with the European continent being particularly ripe for adult-use cannabis legalization right now. It is no secret that lawmakers in Germany are pushing for legalization and that a measure is expected to be formally introduced in the first quarter of this year. When that happens, it will likely set off a cannabis reform butterfly effect in many countries across Europe. Will that extend to Spain?

Spain is home to one of the best cannabis communities on earth, with Barcelona in particular serving as the social cannabis use capital of the world. You will be hard-pressed to find a better place on the planet to be a cannabis consumer than in Spain, with hundreds of private cannabis clubs operating in a legal grey market. However, the current situation in Spain has yielded a populace that is seemingly complacent about cannabis reform, and that has historically complicated legalization efforts.

What Is The Current Status Of Cannabis Policy In Spain?

Cannabis policy in Spain is unique in many ways, with the current approach to cannabis regulation being very limited despite commerce being so commonplace. Private cannabis activity is not prohibited in Spain per se, which is why private cannabis clubs have become so popular. Yet it’s a situation that is not likely sustainable and it would greatly benefit consumers, patients, entrepreneurs, investors, and taxpayers if Spain updated its cannabis laws and regulations.

Cannabis reform efforts in Spain are set to be a very popular topic at the upcoming International Cannabis Business Conference in Barcelona, taking place on March 9.

Attorney Bernardo Soriano Guzmán, from the leading cannabis firm S & F Abogados, will serve as the moderator for the ‘Squaring The Circle Of Industrial Hemp In Spain’ panel at the event. I recently reached out to Bernardo Soriano Guzmán leading up to the conference to get the real scoop about what is going on in Spain.

“During this legislative term, four laws have been presented in the Congress and Senate to regulate adult-use cannabis. One of them has been drafted by S&F lawyers along with other collaborators. A law that fully regulates the production and distribution cycle of cannabis and non-psychoactive cannabis. Despite this intense legislative activity, none of the laws currently have the necessary majority for approval. So, without a doubt, this electoral year that we begin, the regulation of cannabis will be an important point in the political programs and possible electoral alliances for the formation of the next government of Spain, as has happened in Germany in 2021 with the coalition of the traffic light.” — Bernardo Soriano Guzmán, in a statement

Medical Cannabis In Spain

Medical cannabis is already legal in Spain to some degree, and medical cannabis industry licenses are already on the books. With that being said, the regulated medical cannabis industry in Spain is focused on exports and research. Updated domestic safe access provisions and regulations are desperately needed, and fortunately, various lawmakers and advocates are pushing for them.

“Last year 2021, a resolution in the form of a report of conclusions was approved in the Congress of Spain to give access to patients of medicinal cannabis,” Guzmán said. “This report is pending to be implemented once the Spanish Medicines and Health Products Agency (AEMPS) proposes how to do it. The regulation proposed is quite restricted to strictly pharmaceutical channels, with flowers of cannabis not having a predominant role, rather finished products and magistral formulas.”

“Self-cultivation for medicinal use is also not allowed. Additionally in Spain for years licenses for research and production of medicinal cannabis have been granted, a total of 21 licenses having been granted to date December 2022.

In terms of industrial hemp: “The position of the Spanish authorities is very restrictive beyond the classic industrial uses of hemp (production of fiber and seeds). The use of hemp flowers is prohibited, even for the extraction of unregulated cannabinoids (Cannabidiol, cannabigerol, cannabidiol…),” Guzmán said.

“This situation has generated a multitude of proceedings in the courts that have made the Supreme Court recently confirm in a ruling the restrictive vision of the Spanish authorities. This situation clashes quite with the wave of positive changes regarding hemp that are taking place in Europe, especially as a result of the position of the Court of Justice of the European Union. Countries such as France which recently, in a completely contrary line to that of the Spanish authorities, has finally authorized the use of hemp flowers for all uses,” Guzmán concluded.

End